Litigation Details for DOW PHARMACEUTICAL SCIENCES, INC. v. TARO PHARMACEUTICALS U.S.A., INC. (D.N.J. 2017)
✉ Email this page to a colleague
DOW PHARMACEUTICAL SCIENCES, INC. v. TARO PHARMACEUTICALS U.S.A., INC. (D.N.J. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-01-26 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-04-20 |
| Cause | 28:2271 Federal Tort Claims Act | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Parties | TARO PHARMACEUTICALS U.S.A., INC. | ||
| Patents | 9,504,704 | ||
| Attorneys | WILLIAM P. DENI , JR. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in DOW PHARMACEUTICAL SCIENCES, INC. v. TARO PHARMACEUTICALS U.S.A., INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for DOW PHARMACEUTICAL SCIENCES, INC. v. TARO PHARMACEUTICALS U.S.A., INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-01-25 | 1 | United States Patent No. 9,504,704 (“the ’704 patent”) arising under the United States patent laws, Title… THE PATENT IN SUIT 18. The U.S. Patent and Trademark Office (“PTO”…PTO”) issued the ’704 patent on November 29, 2016. The ’704 patent claims, inter alia, formulations of …the ’704 patent and have the right to sue for infringement thereof. A copy of the ’704 patent is attached…Defendants. COMPLAINT FOR PATENT INFRINGEMENT Plaintiffs Dow Pharmaceutical | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
